Evidence map›Paper›PMID 35242220›Full record

ReviewEcancermedicalscience2022

Contingency planning for cancer care in low- and middle-income countries during the COVID-19 pandemic: a rapid assessment for future disaster resilience.

Soo-Peng Teoh, Yee-Yin Hoo, Raul Murillo, María Zuluaga, Audrey Tsunoda, Dorothy Lombe, Richard Sullivan, Nirmala Bhoo-Pathy

Abstract readReview
In one paragraph

Review in Ecancermedicalscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Soo-Peng TeohCentre for Epidemiology and Evidence-Based Medicine, Faculty of Medicine, Universiti Malaya, 50603 Kuala Lumpur, Malaysia.
Yee-Yin HooHospital Serdang, 43000 Kajang, Selangor, Malaysia.
Raul MurilloCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Kra 7° # 40-62, Bogotá, Colombia.
María ZuluagaCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Kra 7° # 40-62, Bogotá, Colombia.
Audrey TsunodaErasto Gaertner Hospital, PPGTS/Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Dorothy LombeRegional Cancer Treatment Services, MidCentral District Health Board, 4410 New Zealand.
Richard SullivanInstitute of Cancer Policy, Global Oncology Group, School of Cancer Sciences, King's College London, Strand, London, WC2R 2LS, United Kingdom.
Nirmala Bhoo-PathyCentre for Epidemiology and Evidence-Based Medicine, Faculty of Medicine, Universiti Malaya, 50603 Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany countries appear to be ill-prepared in their emergency responses towards the Corona Virus Disease 2019 (COVID-19) pandemic, particularly in managing chronic diseases such as cancer. We aimed to gain insight on the preparedness of health systems within low- and middle-income countries (LMICs) in maintaining delivery of cancer care amid the pandemic.

methodsWe performed a rapid review of publications focusing on emergency contingency plans for cancer care during the pandemic in LMICs. An online desk research was conducted to identify relevant policy documents, guidelines or scientific publications.

resultsVery few LMICs had readily accessible documents to ensure continuity in delivery of cancer care during the pandemic. A majority of publications were focused on delivery of cancer treatment whereas early detection, diagnosis and delivery of supportive and survivorship care received very little attention. Far fewer of the published guidelines appear to have been formulated at the national level by governmental agencies. A vast majority of publications constituted consensus guidelines from professional societies, followed by sharing of best practices from local institutions. Overall, three main strategies have been recommended to maintain delivery of cancer care amid the pandemic in LMICs: 1) Modification of cancer treatment regimens, 2) Changes in methods of administration of curative and supportive cancer care and 3) Implementation of generic measures to reduce the risk of COVID-19 infection in healthcare settings.

conclusionAll LMICs should consider collating best practices from the current pandemic and translating them into an explicit cancer preparedness plan, which can be escalated during future disasters.

Indexed as

cancer carecontingency planCOVID-19emergency preparednesslow- and middle-income countries

Identifiers

PMID35242220
PMCPMC8831112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.